Cosgarea Raluca, Ramseier Christoph A, Jepsen Søren, Arweiler Nicole Birgit, Jervøe-Storm Pia Merete, Batori-Andronescu Ionela, Rößler Ralf, Conrad Torsten, Eick Sigrun, Sculean Anton
Department for Periodontology, Operative and Preventive Dentistry, University of Bonn, 53111 Bonn, Germany.
Clinic for Periodontology and Peri-Implant Diseases, Philipps University Marburg, 35033 Marburg, Germany.
Antibiotics (Basel). 2022 May 30;11(6):738. doi: 10.3390/antibiotics11060738.
We evaluated, in this study, the clinical, microbiological and immunological effects of local drug delivery (LDD) or photodynamic therapy (PDT), adjunctive to subgingival instrumentation (SI) in persistent or recurrent periodontal pockets in patients enrolled in supportive periodontal therapy (SPT) after one year. A total of 105 patients enrolled in SPT with persistent/recurrent pockets were randomly treated with SI +PDT or SI + LDD or SI (control). The number of treated sites with bleeding on probing (n BOP+), probing pocket depths (PPD), clinical attachment level (CAL), full-mouth plaque and bleeding scores (gingival bleeding index, %bleeding on probing-BOP) was evaluated at baseline and after 12 months. Additionally, eight periodontopathogens and the immunomarkers IL-1β (interleukin)and MMP-8 (matrix metalloprotease) were quantitatively determined using real-time PCR and ELISA, respectively. All three treatments resulted in statistically significant clinical improvements (p < 0.05) without statistically significant intergroup differences (p > 0.05), which were maintained up to 12 months. The presence of BOP negatively affected the PPD and CAL. Moreover, statistically significantly fewer bleeding sites at 12 months were observed in the test groups (p = 0.049). Several periodontopathogens were reduced after 12 months. In conclusion, the present data indicate that in periodontal patients enrolled in SPT, treatment of persistent/recurrent pockets with SI alone or combined with either PDT or LDD may lead to comparable clinical, microbiological and immunological improvements, which are maintained up to 12 months. Secondly, the presence of BOP directly impacts the PPD and CAL.
在本研究中,我们评估了在接受支持性牙周治疗(SPT)一年后,局部药物递送(LDD)或光动力疗法(PDT)辅助龈下器械治疗(SI)对持续性或复发性牙周袋患者的临床、微生物学和免疫学影响。共有105名患有持续性/复发性牙周袋的SPT患者被随机分为接受SI + PDT、SI + LDD或SI(对照组)治疗。在基线和12个月后评估探诊出血(nBOP+)的治疗部位数量、探诊牙周袋深度(PPD)、临床附着水平(CAL)、全口菌斑和出血评分(牙龈出血指数、探诊出血百分比 - BOP)。此外,分别使用实时PCR和ELISA定量测定了8种牙周病原体以及免疫标志物白细胞介素 - 1β(IL - 1β)和基质金属蛋白酶 - 8(MMP - 8)。所有三种治疗均导致统计学上显著的临床改善(p < 0.05),且组间差异无统计学意义(p > 0.05),这种情况持续到12个月。BOP的存在对PPD和CAL有负面影响。此外,在试验组中观察到12个月时出血部位在统计学上显著减少(p = 0.049)。12个月后几种牙周病原体减少。总之,目前的数据表明,在接受SPT的牙周病患者中,单独使用SI或与PDT或LDD联合治疗持续性/复发性牙周袋可能会带来相当的临床、微生物学和免疫学改善,且这种改善可持续12个月。其次,BOP的存在直接影响PPD和CAL。